References
- Kwong Y L. Arsenic trioxide in the treatment of haematological malignancies. Expert Opin Drug Saf 2004; 3: 589–597
- Au W Y, Chim C S, Lie A K, Liang R, Kwong Y L. Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide. Br J Haematol 2002; 117: 130–132
- Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 1995; 141: 198–209
- Au W Y, Tam S, Fong B M, Kwong Y L. Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia. Blood 2006; 107: 3012–3013
- Douenias R, Rich M, Badlani G, Mazor D, Smith A. Predisposing factors in bladder calculi. Review of 100 cases. Urology 1991; 37: 240–243
- Trinchieri A, Castelnuovo C, Lizzano R, Zanetti G. Calcium stone disease: a multiform reality. Urol Res 2005; 33: 194–198
- Li W, Wei C, Zhang C, van Hulle M, Cornelis R, Zhang X. A survey of arsenic species in Chinese seafood. Food Chem Toxicol 2003; 41: 1103–1110
- Scott R, Cunningham C, McLelland A, Fell G S, Fitzgerald-Finch O P, McKellar N. The importance of cadmium as a factor in calcified upper urinary tract stone disease—a prospective 7-year study. Br J Urol 1982; 54: 584–589
- Yazaki T, Umeyama T, Kaneko S, Kiriyama I, Ishihawa H, Koiso K. Multi-element analysis of kidney tissue with renal calculi. Urology 1991; 38: 290–293